AA

Amit Anand

Active Director Director DIN 10226735
DIN 10226735 First appointment Jul 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value •••• Premium profile

About Amit Anand

Data last updated:

Amit Anand is a Director at Astrovita Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Astrovita Pharmaceuticals Private Limited reported revenue of ₹27.4 Lakh (FY 2025).

DIN 10226735
Primary Designation Director
Industry Pharma
First Appointment 05 Jul 2023
Oldest Company Age 3 yrs
Largest company Astrovita Pharmaceuticals Private Limited · ₹27.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director05 Jul 20232023₹27.4 Lakh (FY 2025)Active

Board colleagues of Amit Anand

NameDINCompanyDesignation
Rati10226734Astrovita Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Astrovita Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Amit Anand

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amit Anand

Amit Anand currently holds 1 directorship: Astrovita Pharmaceuticals Private Limited (Director, since 05 Jul 2023, revenue ₹27.4 Lakh (FY 2025)).

Amit Anand was first appointed on 05 Jul 2023 as Director at Astrovita Pharmaceuticals Private Limited.

The current boards of Amit Anand's companies include Rati (Astrovita Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available